Acute Myeloid Leukemia Global Market Report 2024

Global Acute Myeloid Leukemia Market Report 2024

Acute Myeloid Leukemia Global Market Report 2024 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Name: Acute Myeloid Leukemia Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Acute Myeloid Leukemia Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 200 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Acute Myeloid Leukemia Global Market Report 2024

Proud Members Of

Acute Myeloid Leukemia Market Definition

Acute myeloid leukemia (AML) is a type of blood cancer that occurs due to abnormal white blood cell in bone marrow. Myeloblasts, also known as leukemic blasts, or excessive production of immature white blood cells, are the hallmark of AML. The bone marrow is crowded with these cells, which stops it from producing healthy blood cells.

The main acute myeloid leukemia treatment types include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. The different acute myeloid leukemia chemotherapies include cytarabine, anthracycline drugs, alkylating agents, anti-metabolites, tyrosine kinase inhibitors, and hormonal therapy. They are of various regimens such as DC regimen, AVD regimen, and VCD regimen. Acute myeloid leukemia is treated by different end-users such as hospitals, retail drug stores, ambulatory care centers, and clinics.

Acute Myeloid Leukemia Market Segmentation

The acute myeloid leukemia market covered in this report is segmented –

1) By Treatment Type: Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy

2) By Chemotherapy: Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy

3) By Regimen: DC Regimen, AVD Regimen, VCD Regimen

4) By End-User: Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics

Global Acute Myeloid Leukemia Market Size 2023 to 2028: Graph

Acute Myeloid Leukemia Market Size 2024 And Growth Rate

The acute myeloid leukemia market size has grown strongly in recent years. It will grow from $2.21 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth aging population, environmental factors, genetic predisposition, limited treatment options, medical advancements.

Acute Myeloid Leukemia Market Growth Forecast

The acute myeloid leukemia market size is expected to see strong growth in the next few years. It will grow to $3.21 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing advancements in targeted therapies, immunotherapies development, precision medicine approaches, increased awareness and early detection, collaborative research initiatives. Major trends in the forecast period include emphasis on minimal residual disease monitoring, integration of artificial intelligence (ai) in treatment decision support, focus on supportive care and quality of life interventions, collaborative research initiatives and clinical trials, patient advocacy and empowerment programs.

Book your 30 minutes free consultation with our research experts

Acute Myeloid Leukemia Market Driver: Geriatric Population And Unmet Healthcare Needs Fuel Growth In Acute Myeloid Leukemia Market

The increase in the older population base and growing unmet healthcare needs is expected to propel the growth of the acute myeloid leukemia market over the coming years. The geriatric population and growing unmet healthcare are defined as the elderly population, people aged 65 and over suffering from health issues like acute myeloid leukemia. For instance, according to the American Cancer Society USA (ACS), a nationwide voluntary health organization, in 2022, AML was commonly found in elderly people with an average age at diagnosis being 68, and survival of elderly AML patients remained remarkably low. It affected approximately 60,650 people in 2022 and caused 24000 deaths. Therefore, the geriatric population base and growing unmet healthcare needs drive the gelatin market.

Acute Myeloid Leukemia Market Driver: Rising Adoption Of Personalized Medicine To Drive Market Growth

The increasing adoption of personalized medicine is expected to propel the growth of acute myeloid leukemia market going forward. Personalized medicine is an innovative approach to medical treatment and healthcare that considers individual differences in patients' genes, environments, and lifestyles. In acute myeloid leukemia (AML), personalized medicine is employed through molecular profiling to identify specific genetic mutations and biomarkers unique to individual patients. This information guides the selection of targeted therapies and tailored treatment plans, optimizing the effectiveness of interventions while minimizing adverse effects for a more personalized and precise approach to AML management. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the increasing adoption of personalized medicine is driving the growth of acute myeloid leukemia market.

Global Acute Myeloid Leukemia Market Major Players

Major companies operating in the acute myeloid leukemia market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical, Celgene Corporation, Astellas Pharma, Servier Pharmaceuticals, CSPC Pharmaceutical Group, Genmab AS, Zhejiang Medicine Co. Ltd., Syndax Pharmaceuticals Inc., Astex Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Ambit Biosciences Corporation, Agios Pharmaceuticals Inc., Neomed Management AS, Oncolyze Inc., TC BioPharm, VERASTEM INC., Mirati Therapeutics Inc., Sunshine Lake Pharma, Sunesis Pharmaceuticals Inc.

Global Acute Myeloid Leukemia Market Trend: Innovative Research And Development Initiatives Transforming The Acute Myeloid Leukemia Market

Growing investments in R&D using the pharmaceutical groups are a key trend gaining popularity in the acute myeloid leukemia market. R&D is used to develop new and improved products and services to fulfill the needs of drug development. For instance, in May 2022, according to National Library of Medicine, a US-based national medical library, a study with the title ‘Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs. Physician's Choice in Newly Diagnosed FLT3-ITD+ AML (Q-SOC)’ is in Phase III of clinical trials. It commenced in November 2021 and is expected to conclude by March 2025.

Global Acute Myeloid Leukemia Market Trend: Pharmaceutical Companies Enhancing Acute Myeloid Leukemia Treatment Armamentarium With Quizartinib Approval

Major companies operating in the acute myeloid leukemia markets are focused on developing advanced drug solutions such as maintenance monotherapy to expand their product portfolios to improve patient outcomes and address unmet medical needs. Maintenance monotherapy refers to a medical treatment approach where a single therapeutic agent is administered to a patient as an ongoing, long-term therapy to prevent the recurrence or progression of a medical condition. For instance, in July 2023, Daiichi Sankyo Company Limited, a Japan-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for quizartinib (Vanflyta) in combination with standard cytarabine and anthracycline induction, followed by cytarabine consolidation, and as maintenance monotherapy for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults with FLT3 internal tandem duplication (ITD)-positive status, as determined by an FDA-approved test. The LeukoStrat CDx FLT3 Mutation Assay has also been approved as a companion diagnostic for Vanflyta. The approval is based on positive results from the QuANTUM-First trial, showing a statistically significant improvement in overall survival for patients receiving quizartinib compared to a placebo. Quizartinib's recommended dosage varies during induction, consolidation, and maintenance phases. The drug is not indicated as maintenance monotherapy following allogeneic hematopoietic stem cell transplantation.

Acute Myeloid Leukemia Market Merger And Acquisition:

Qiagen And Servier Collaborate To Develop Companion Diagnostic Test For AML Treatment

In March 2023, QIAGEN, a Netherlands-based biotechnology company, partnered with Servier Laboratories, for an undisclosed amount. This partnership aims to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor intended for treating acute myeloid leukemia (AML). Under this Master Collaboration Agreement, QIAGEN will create and validate a real-time in vitro PCR test designed to detect IDH1 gene mutations in AML patients using blood and bone marrow samples. This collaboration enhances the global accessibility of TIBSOVO for AML patients with IDH1 mutations and reinforces QIAGEN's role in developing companion diagnostics for emerging biomarkers in onco-hematology, furthering precision medicine initiatives. Servier Laboratories, a France-based pharmaceutical company

Regional Insights For The Global Acute Myeloid Leukemia Market

North America was the largest region in the acute myeloid leukemia market in 2023. The regions covered in the acute myeloid leukemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute myeloid leukemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The acute myeloid leukemia market includes revenue earned by drugs such as DC regimen, AVD Regimen, VCD regimen, cytarabine, vidaza, dacogen, midostaurin, quizartinib, vosaroxin that are used for the treatment of acute myeloid leukemia. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The acute myeloid leukemia market research report is one of a series of new reports from The Business Research Company that provides acute myeloid leukemia market statistics, including acute myeloid leukemia industry global market size, regional shares, competitors with a acute myeloid leukemia market share, detailed acute myeloid leukemia market segments, market trends and opportunities, and any further data you may need to thrive in the acute myeloid leukemia industry. This acute myeloid leukemia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Acute Myeloid Leukemia Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$2.39 billion
Revenue Forecast In 2033	$3.21 billion
Growth Rate	CAGR of 7.6% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Treatment Type: Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy 2) By Chemotherapy: Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy 3) By Regimen: DC Regimen, AVD Regimen, VCD Regimen 4) By End-User: Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation); Bristol Myers Squibb Company; GlaxoSmithKline plc; Takeda Pharmaceuticals; Amgen Inc.; Otsuka Holdings Co. Ltd.; Teva Pharmaceutical; Celgene Corporation; Astellas Pharma; Servier Pharmaceuticals; CSPC Pharmaceutical Group; Genmab AS; Zhejiang Medicine Co. Ltd.; Syndax Pharmaceuticals Inc.; Astex Pharmaceuticals Inc.; MEI Pharma Inc.; SELLAS Life Sciences Group; Ambit Biosciences Corporation; Agios Pharmaceuticals Inc.; Neomed Management AS; Oncolyze Inc.; TC BioPharm; VERASTEM INC.; Mirati Therapeutics Inc.; Sunshine Lake Pharma; Sunesis Pharmaceuticals Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Acute Myeloid Leukemia Market Characteristics

3. Acute Myeloid Leukemia Market Trends And Strategies

4. Acute Myeloid Leukemia Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Acute Myeloid Leukemia Market Size and Growth

5.1. Global Acute Myeloid Leukemia Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Acute Myeloid Leukemia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Acute Myeloid Leukemia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acute Myeloid Leukemia Market Segmentation

6.1. Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Chemotherapy

Radiation therapy

Stem Cell Transplant

Targeted Therapy

6.2. Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Cytarabine

Anthracycline Drugs

Alkylating Agents

Anti-metabolites

Tyrosine Kinase Inhibitors

Hormonal Therapy

6.3. Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

DC Regimen

AVD Regimen

VCD Regimen

6.4. Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital

Retails Drug Stores

Ambulatory Care Centers

Clinics

7. Acute Myeloid Leukemia Market Regional And Country Analysis

7.1. Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acute Myeloid Leukemia Market

8.1. Asia-Pacific Acute Myeloid Leukemia Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acute Myeloid Leukemia Market

9.1. China Acute Myeloid Leukemia Market Overview

9.2. China Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acute Myeloid Leukemia Market

10.1. India Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acute Myeloid Leukemia Market

11.1. Japan Acute Myeloid Leukemia Market Overview

11.2. Japan Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acute Myeloid Leukemia Market

12.1. Australia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acute Myeloid Leukemia Market

13.1. Indonesia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acute Myeloid Leukemia Market

14.1. South Korea Acute Myeloid Leukemia Market Overview

14.2. South Korea Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acute Myeloid Leukemia Market

15.1. Western Europe Acute Myeloid Leukemia Market Overview

15.2. Western Europe Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acute Myeloid Leukemia Market

16.1. UK Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acute Myeloid Leukemia Market

17.1. Germany Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acute Myeloid Leukemia Market

18.1. France Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acute Myeloid Leukemia Market

19.1. Italy Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acute Myeloid Leukemia Market

20.1. Spain Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acute Myeloid Leukemia Market

21.1. Eastern Europe Acute Myeloid Leukemia Market Overview

21.2. Eastern Europe Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acute Myeloid Leukemia Market

22.1. Russia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acute Myeloid Leukemia Market

23.1. North America Acute Myeloid Leukemia Market Overview

23.2. North America Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acute Myeloid Leukemia Market

24.1. USA Acute Myeloid Leukemia Market Overview

24.2. USA Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acute Myeloid Leukemia Market

25.1. Canada Acute Myeloid Leukemia Market Overview

25.2. Canada Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acute Myeloid Leukemia Market

26.1. South America Acute Myeloid Leukemia Market Overview

26.2. South America Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acute Myeloid Leukemia Market

27.1. Brazil Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acute Myeloid Leukemia Market

28.1. Middle East Acute Myeloid Leukemia Market Overview

28.2. Middle East Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acute Myeloid Leukemia Market

29.1. Africa Acute Myeloid Leukemia Market Overview

29.2. Africa Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acute Myeloid Leukemia Market Competitive Landscape And Company Profiles

30.1. Acute Myeloid Leukemia Market Competitive Landscape

30.2. Acute Myeloid Leukemia Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. F. Hoffmann-La Roche AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. AbbVie Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Novartis AG

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Sanofi-Aventis (Genzyme Corporation)

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Acute Myeloid Leukemia Market Other Major And Innovative Companies

31.1. Bristol Myers Squibb Company

31.2. GlaxoSmithKline plc

31.3. Takeda Pharmaceuticals

31.4. Amgen Inc.

31.5. Otsuka Holdings Co. Ltd.

31.6. Teva Pharmaceutical

31.7. Celgene Corporation

31.8. Astellas Pharma

31.9. Servier Pharmaceuticals

31.10. CSPC Pharmaceutical Group

31.11. Genmab AS

31.12. Zhejiang Medicine Co. Ltd.

31.13. Syndax Pharmaceuticals Inc.

31.14. Astex Pharmaceuticals Inc.

31.15. MEI Pharma Inc.

32. Global Acute Myeloid Leukemia Market Competitive Benchmarking

33. Global Acute Myeloid Leukemia Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acute Myeloid Leukemia Market

35. Acute Myeloid Leukemia Market Future Outlook and Potential Analysis

35.1 Acute Myeloid Leukemia Market In 2028 - Countries Offering Most New Opportunities

35.2 Acute Myeloid Leukemia Market In 2028 - Segments Offering Most New Opportunities

35.3 Acute Myeloid Leukemia Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Pfizer Inc. Financial Performance

Table 76: F. Hoffmann-La Roche AG Financial Performance

Table 77: AbbVie Inc. Financial Performance

Table 78: Novartis AG Financial Performance

Table 79: Sanofi-Aventis (Genzyme Corporation) Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Pfizer Inc. Financial Performance

Figure 76: F. Hoffmann-La Roche AG Financial Performance

Figure 77: AbbVie Inc. Financial Performance

Figure 78: Novartis AG Financial Performance

Figure 79: Sanofi-Aventis (Genzyme Corporation) Financial Performance

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

Pain Management Devices And Therapies Global Market Report 2024 – By Type (Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps), By Neurostimulation Devices (Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices), By Electrical Stimulation Devices (Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Combination Devices, Electrotherapy Devices, TNS), By Ablation Devices (Radiofrequency Ablation Devices, Cryoablation Devices), By Analgesic Infusion Pumps (Intrathecal Infusion Pumps, External Infusion Pumps), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Trauma) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Metabolomics Global Market Report 2024 – By Product & Service (Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Skin Cancer Drugs Global Market Report 2024 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Lung Cancer Drugs Global Market Report 2024 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pancreatic Cancer Drugs Global Market Report 2024 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the acute myeloid leukemia market?

How will the acute myeloid leukemia market drivers and restraints affect the acute myeloid leukemia market dynamics? What forces will shape the acute myeloid leukemia industry going forward?

The acute myeloid leukemia market major growth driver - geriatric population and unmet healthcare needs fuel growth in acute myeloid leukemia market. For further insights on the acute myeloid leukemia market, request a sample here

What is the forecast market size or the forecast market value of the acute myeloid leukemia market ?

The acute myeloid leukemia market size has grown strongly in recent years. It will grow from $2.21 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to growth aging population, environmental factors, genetic predisposition, limited treatment options, medical advancements. The acute myeloid leukemia market size is expected to see strong growth in the next few years. It will grow to $3.21 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing advancements in targeted therapies, immunotherapies development, precision medicine approaches, increased awareness and early detection, collaborative research initiatives. Major trends in the forecast period include emphasis on minimal residual disease monitoring, integration of artificial intelligence (ai) in treatment decision support, focus on supportive care and quality of life interventions, collaborative research initiatives and clinical trials, patient advocacy and empowerment programs. For further insights on the acute myeloid leukemia market, request a sample here

How is the acute myeloid leukemia market segmented?

The acute myeloid leukemia market is segmented
1) By Treatment Type: Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy
2) By Chemotherapy: Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy
3) By Regimen: DC Regimen, AVD Regimen, VCD Regimen
4) By End-User: Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics For further insights on the acute myeloid leukemia market, request a sample here

Which region has the largest share of the acute myeloid leukemia market? What are the other regions covered in the report?

North America was the largest region in the acute myeloid leukemia market in 2023. The regions covered in the acute myeloid leukemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the acute myeloid leukemia market, request a sample here.

Who are the major players in the acute myeloid leukemia market?

What are the key trends in the acute myeloid leukemia market?

Major trend in the acute myeloid leukemia market - innovative research and development initiatives transforming the acute myeloid leukemia market. For further insights on the acute myeloid leukemia market, request a sample here.

What are the major opportunities in the acute myeloid leukemia market? What are the strategies for the acute myeloid leukemia market?

For detailed insights on the major opportunities and strategies in the acute myeloid leukemia market, request a sample here.

How does the acute myeloid leukemia market relate to the overall economy and other similar markets?

For detailed insights on acute myeloid leukemia market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the acute myeloid leukemia industry?

For detailed insights on the mergers and acquisitions in the acute myeloid leukemia industry, request a sample here.

What are the key dynamics influencing the acute myeloid leukemia market growth? SWOT analysis of the acute myeloid leukemia market.

For detailed insights on the key dynamics influencing the acute myeloid leukemia market growth and SWOT analysis of the acute myeloid leukemia industry, request a sample here.